CBD reduced brain inflammation and improved memory in diabetic rats with impaired brain blood flow
CBD treatment improved memory and reduced brain inflammation markers in middle-aged diabetic rats subjected to chronic cerebral hypoperfusion, though it did not affect neuroplasticity markers.
Quick Facts
What This Study Found
Diabetes worsened cognitive deficits from chronic cerebral hypoperfusion in middle-aged rats. CBD (10 mg/kg daily for 30 days) improved memory performance and reduced hippocampal levels of multiple inflammation markers (iNOS, Iba1, GFAP, arginase 1). CBD also attenuated the BDNF decrease caused by hypoperfusion. CBD did not affect neuroplasticity markers (GAP-43, synaptophysin) and caused weight loss.
Key Numbers
CBD dose: 10 mg/kg daily for 30 days. Reduced iNOS, Iba1, GFAP, and arginase 1 in hippocampus. Preserved BDNF levels. Did not affect GAP-43 or synaptophysin. Caused weight loss.
How They Did This
Middle-aged rats (14 months) were made diabetic with streptozotocin, subjected to chronic cerebral hypoperfusion surgery, then treated with CBD 10 mg/kg/day for 30 days. Memory, inflammation markers, and neuroplasticity markers were assessed.
Why This Research Matters
Diabetes and aging together dramatically increase the risk of cognitive decline from reduced brain blood flow. Finding that CBD can protect against this combined insult suggests it targets the inflammatory pathway that worsens the damage.
The Bigger Picture
With diabetes and vascular disease both increasing globally, the intersection of these conditions with cognitive decline is a growing public health concern. CBD's anti-inflammatory properties may address a key mechanism in this process.
What This Study Doesn't Tell Us
Animal study using a pharmacological diabetes model. Only one CBD dose tested. The weight loss effect of CBD needs further investigation. Results may not translate directly to humans.
Questions This Raises
- ?Would CBD be effective in human patients with diabetes and cerebrovascular disease?
- ?Is the memory improvement driven entirely by inflammation reduction?
- ?Could combining CBD with standard diabetes treatment provide synergistic protection?
Trust & Context
- Key Stat:
- CBD reduced four inflammation markers in the hippocampus
- Evidence Grade:
- Preliminary: single animal study with one dose in a specific disease model.
- Study Age:
- Published in 2019.
- Original Title:
- Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.
- Published In:
- Neurotoxicity research, 35(2), 463-474 (2019)
- Authors:
- Santiago, Amanda Nunes, Mori, Marco Aurélio(4), Guimarães, Francisco Silveira(8), Milani, Humberto, Weffort de Oliveira, Rúbia Maria
- Database ID:
- RTHC-02276
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is chronic cerebral hypoperfusion?
It refers to chronically reduced blood flow to the brain, which can occur with aging, diabetes, and cardiovascular disease. Over time, it leads to cognitive decline and increases dementia risk.
Why did CBD cause weight loss?
CBD-induced weight loss has been observed in other studies and may relate to its effects on appetite regulation, fat metabolism, or energy expenditure. This effect was seen in both sham and hypoperfusion groups.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02276APA
Santiago, Amanda Nunes; Mori, Marco Aurélio; Guimarães, Francisco Silveira; Milani, Humberto; Weffort de Oliveira, Rúbia Maria. (2019). Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.. Neurotoxicity research, 35(2), 463-474. https://doi.org/10.1007/s12640-018-9972-5
MLA
Santiago, Amanda Nunes, et al. "Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.." Neurotoxicity research, 2019. https://doi.org/10.1007/s12640-018-9972-5
RethinkTHC
RethinkTHC Research Database. "Effects of Cannabidiol on Diabetes Outcomes and Chronic Cere..." RTHC-02276. Retrieved from https://rethinkthc.com/research/santiago-2019-effects-of-cannabidiol-on
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.